Osteoporosis

Top Story

Denosumab superior to risedronate for spine, hip BMD through 2 years

Denosumab superior to risedronate for spine, hip BMD through 2 years
October 23, 2018
In the Journals

Improved quadricep strength linked to better function in women with OA

October 11, 2018
Modest improvements in quadricep strength are associated with better performance in chair-stand tests among women — but not men — who are at risk for knee…
In the Journals

Wearable devices linked to increased activity in rheumatic diseases

October 11, 2018
The use of wearable devices that track movement is effective in significantly increasing the amount of and time spent performing moderate to vigorous physical activity…
Meeting News

Bone mineral density gains from Tymlos for osteoporosis maintained following alendronate

October 5, 2018
Gains in ultradistal radius bone mineral density demonstrated by postmenopausal women with osteoporosis who had been treated with abaloparatide for 18 months were…
More Headlines »
Case Report

Spontaneous Bilateral Femoral Fractures After High-Dose Zoledronic Acid

Orthopedics, November/December 2015, Volume 38 Issue 11
The authors report a case of spontaneous bilateral diaphyseal femoral fractures believed to be caused by…
More »
CME ABIM MOC

Ace the Case: 55-Year-Old Woman with Type 1 Diabetes Mellitus Presents with Concerns About Osteoporosis

There is no commercial support for this activity.

This educational activity will discuss the management of a 55-year-old, postmenopausal woman who presents for follow-up…
More »
Video
Meeting News

VIDEO: Women with osteoporosis had reduction in vertebral, nonvertebral fractures with abaloparatide, alendronate

November 8, 2017
More »